Incidence of Malignancy After Living Kidney Transplantation: A Multicen-Ter Study From Iran Publisher



Einollahi B¹ ; Rostami Z¹ ; Nourbala MH¹ ; Lessanpezeshki M² ; Simforoosh N³ ; Nemati E¹ ; Pourfarziani V¹ ; Beiraghdar F¹ ; Nafar M³ ; Pourrezagholi F³ ; Mazdeh MM² ; Amini M² ; Ahmadpour P³ ; Makhdoomi K⁴ Show All Authors Show Affiliations
Source: Journal of Cancer Published:2012

Abstract

Malignancy is a common complication after renal transplantation. However, limited data are available on post-transplant malignancy in living kidney transplantation. Therefore, we made a plan to evaluate the incidence and types of malignancies, association with the main risk factors and patient survival in a large population of living kidney transplantation. We conducted a large retrospective multicenter study on 12525 renal recipients, accounting for up to 59% of all kidney transplantation in Iran during 22 years follow up period. All information was collected from observation of individual notes or computerized records for transplant patients. Two hundred and sixty-six biopsy-proven malignancies were collected from 16 Transplant Centers in Iran; 26 different type of malignancy categorized in 5 groups were detected. The mean age of patients was 46.2±12.9 years, mean age at tumor diagnosis was 50.8±13.2 years and average time between transplantation and detection of malignancy was 50.0±48.4 months. Overall tumor incidence in recipients was 2%. Kaposis' sarcoma was the most common type of tumor. The overall mean survival time was 117.1 months (95% CI: 104.9-129.3). In multivariate analysis, the only independent risk factor associated with mortality was type of malignancy. This study revealed the lowest malignancy incidence in living unrelated kidney transplantation. © Ivyspring International Publisher.